These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 39066239)

  • 1. Downregulation of miRNA-26a by HIV-1 Enhances CD59 Expression and Packaging, Impacting Virus Susceptibility to Antibody-Dependent Complement-Mediated Lysis.
    Bellini N; Ye C; Ajibola O; Murooka TT; Lodge R; Cohen ÉA
    Viruses; 2024 Jul; 16(7):. PubMed ID: 39066239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockage of CD59 Function Restores Activities of Neutralizing and Nonneutralizing Antibodies in Triggering Antibody-Dependent Complement-Mediated Lysis of HIV-1 Virions and Provirus-Activated Latently Infected Cells.
    Yang K; Lan J; Shepherd N; Hu N; Xing Y; Byrd D; Amet T; Jewell C; Gupta S; Kounga C; Gao J; Yu Q
    J Virol; 2015 Sep; 89(18):9393-406. PubMed ID: 26136568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosylphosphatidylinositol Anchor Deficiency Attenuates the Production of Infectious HIV-1 and Renders Virions Sensitive to Complement Attack.
    Amet T; Lan J; Shepherd N; Yang K; Byrd D; Xing Y; Yu Q
    AIDS Res Hum Retroviruses; 2016; 32(10-11):1100-1112. PubMed ID: 27231035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Provirus activation plus CD59 blockage triggers antibody-dependent complement-mediated lysis of latently HIV-1-infected cells.
    Lan J; Yang K; Byrd D; Hu N; Amet T; Shepherd N; Desai M; Gao J; Gupta S; Sun Y; Yu Q
    J Immunol; 2014 Oct; 193(7):3577-89. PubMed ID: 25149467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-dependent complement-mediated cytotoxicity in sera from patients with HIV-1 infection is controlled by CD55 and CD59.
    Schmitz J; Zimmer JP; Kluxen B; Aries S; Bögel M; Gigli I; Schmitz H
    J Clin Invest; 1995 Sep; 96(3):1520-6. PubMed ID: 7544808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD59 incorporation protects hepatitis C virus against complement-mediated destruction.
    Amet T; Ghabril M; Chalasani N; Byrd D; Hu N; Grantham A; Liu Z; Qin X; He JJ; Yu Q
    Hepatology; 2012 Feb; 55(2):354-63. PubMed ID: 21932413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A high-affinity inhibitor of human CD59 enhances complement-mediated virolysis of HIV-1: implications for treatment of HIV-1/AIDS.
    Hu W; Yu Q; Hu N; Byrd D; Amet T; Shikuma C; Shiramizu B; Halperin JA; Qin X
    J Immunol; 2010 Jan; 184(1):359-68. PubMed ID: 19955519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4- and Time-Dependent Susceptibility of HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity.
    Lee WS; Prévost J; Richard J; van der Sluis RM; Lewin SR; Pazgier M; Finzi A; Parsons MS; Kent SJ
    J Virol; 2019 May; 93(10):. PubMed ID: 30842324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Cross-Clade Characterization of Antibody-Mediated Recognition, Complement-Mediated Lysis, and Cell-Mediated Cytotoxicity of HIV-1 Envelope-Specific Antibodies toward Eradication of the HIV-1 Reservoir.
    Mujib S; Liu J; Rahman AKMN; Schwartz JA; Bonner P; Yue FY; Ostrowski MA
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28592534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA regulation and its effects on cellular transcriptome in human immunodeficiency virus-1 (HIV-1) infected individuals with distinct viral load and CD4 cell counts.
    Duskova K; Nagilla P; Le HS; Iyer P; Thalamuthu A; Martinson J; Bar-Joseph Z; Buchanan W; Rinaldo C; Ayyavoo V
    BMC Infect Dis; 2013 May; 13():250. PubMed ID: 23721325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incomplete Downregulation of CD4 Expression Affects HIV-1 Env Conformation and Antibody-Dependent Cellular Cytotoxicity Responses.
    Prévost J; Richard J; Medjahed H; Alexander A; Jones J; Kappes JC; Ochsenbauer C; Finzi A
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1.
    Saifuddin M; Parker CJ; Peeples ME; Gorny MK; Zolla-Pazner S; Ghassemi M; Rooney IA; Atkinson JP; Spear GT
    J Exp Med; 1995 Aug; 182(2):501-9. PubMed ID: 7543140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection.
    Montefiori DC; Cornell RJ; Zhou JY; Zhou JT; Hirsch VM; Johnson PR
    Virology; 1994 Nov; 205(1):82-92. PubMed ID: 7526538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 Vpu Promotes Phagocytosis of Infected CD4
    Cong L; Sugden SM; Leclair P; Lim CJ; Pham TNQ; Cohen ÉA
    mBio; 2021 Aug; 12(4):e0192021. PubMed ID: 34425695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of the Let-7 family of microRNAs in CD4+ T cells alters IL-10 expression.
    Swaminathan S; Suzuki K; Seddiki N; Kaplan W; Cowley MJ; Hood CL; Clancy JL; Murray DD; Méndez C; Gelgor L; Anderson B; Roth N; Cooper DA; Kelleher AD
    J Immunol; 2012 Jun; 188(12):6238-46. PubMed ID: 22586040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD59 association with infectious bronchitis virus particles protects against antibody-dependent complement-mediated lysis.
    Wei Y; Ji Y; Guo H; Zhi X; Han S; Zhang Y; Gao Y; Chang Y; Yan D; Li K; Liu DX; Sun S
    J Gen Virol; 2017 Nov; 98(11):2725-2730. PubMed ID: 29068273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of the membrane inhibitor of complement-mediated cytolysis CD59 on T-lymphocytes of HIV-infected patients.
    Weiss L; Okada N; Haeffner-Cavaillon N; Hattori T; Faucher C; Kazatchkine MD; Okada H
    AIDS; 1992 Apr; 6(4):379-85. PubMed ID: 1377473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 regulates cellular resistance to complement lysis through enhanced expression of CD59.
    Donev RM; Cole DS; Sivasankar B; Hughes TR; Morgan BP
    Cancer Res; 2006 Feb; 66(4):2451-8. PubMed ID: 16489052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD59 blockade enhances antigen-specific CD4+ T cell responses in humans: a new target for cancer immunotherapy?
    Sivasankar B; Longhi MP; Gallagher KM; Betts GJ; Morgan BP; Godkin AJ; Gallimore AM
    J Immunol; 2009 May; 182(9):5203-7. PubMed ID: 19380765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stable changes in CD4+ T lymphocyte miRNA expression after exposure to HIV-1.
    Bignami F; Pilotti E; Bertoncelli L; Ronzi P; Gulli M; Marmiroli N; Magnani G; Pinti M; Lopalco L; Mussini C; Ruotolo R; Galli M; Cossarizza A; Casoli C
    Blood; 2012 Jun; 119(26):6259-67. PubMed ID: 22286198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.